news_6

Humanigen Reports Positive Phase 3 Topline Results Demonstrating That Lenzilumab™ Improves Survival Without Need for Mechanical Ventilation in Hospitalized Patients With COVID-19

Lenzilumab improved the relative likelihood of survival without need for invasive mechanical ventilation (IMV) by 54%, achieving the primary endpoint...

news_6

NTT Named a Leader in the Gartner Magic Quadrant for Network Services, Global Ranked Highest in Gartner Critical Capabilities for Network Services, Global

NTT is positioned furthest and highest for “Completeness of Vision” and “Ability to execute” respectively in the Gartner Magic Quadrant....